Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 46% ± 24% | |
GABAergic neuron | 8 studies | 42% ± 23% | |
interneuron | 6 studies | 36% ± 19% | |
oligodendrocyte precursor cell | 6 studies | 24% ± 10% | |
neuron | 4 studies | 26% ± 8% | |
astrocyte | 4 studies | 26% ± 9% | |
endothelial cell of lymphatic vessel | 4 studies | 26% ± 8% | |
endothelial cell | 3 studies | 37% ± 13% | |
GABAergic interneuron | 3 studies | 33% ± 7% | |
granule cell | 3 studies | 26% ± 3% | |
oligodendrocyte | 3 studies | 29% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 34% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 3354.86 | 2585 / 2642 | 90% | 8.44 | 632 / 705 |
thymus | 97% | 786.98 | 634 / 653 | 88% | 4.46 | 531 / 605 |
prostate | 84% | 559.43 | 207 / 245 | 82% | 2.27 | 412 / 502 |
adrenal gland | 83% | 521.57 | 214 / 258 | 81% | 12.00 | 187 / 230 |
kidney | 85% | 516.10 | 76 / 89 | 72% | 3.22 | 649 / 901 |
pancreas | 78% | 407.34 | 257 / 328 | 74% | 2.82 | 132 / 178 |
stomach | 89% | 487.57 | 319 / 359 | 52% | 1.83 | 149 / 286 |
bladder | 90% | 579.24 | 19 / 21 | 43% | 1.40 | 218 / 504 |
ovary | 80% | 529.20 | 144 / 180 | 42% | 0.92 | 179 / 430 |
intestine | 75% | 503.64 | 727 / 966 | 43% | 1.17 | 228 / 527 |
lung | 46% | 225.43 | 267 / 578 | 54% | 1.75 | 620 / 1155 |
breast | 42% | 227.52 | 192 / 459 | 56% | 1.67 | 629 / 1118 |
blood vessel | 97% | 1185.50 | 1297 / 1335 | 0% | 0 | 0 / 0 |
heart | 87% | 1725.47 | 747 / 861 | 0% | 0 | 0 / 0 |
esophagus | 38% | 210.44 | 551 / 1445 | 44% | 1.57 | 81 / 183 |
uterus | 52% | 248.29 | 88 / 170 | 30% | 0.89 | 136 / 459 |
skin | 54% | 280.32 | 970 / 1809 | 4% | 0.09 | 21 / 472 |
eye | 0% | 0 | 0 / 0 | 55% | 1.40 | 44 / 80 |
liver | 0% | 0 | 0 / 226 | 21% | 0.46 | 84 / 406 |
adipose | 17% | 75.09 | 200 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.19 | 4 / 45 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
peripheral blood | 3% | 13.04 | 31 / 929 | 0% | 0 | 0 / 0 |
muscle | 2% | 13.40 | 19 / 803 | 0% | 0 | 0 / 0 |
spleen | 1% | 5.49 | 3 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | SGSM1 |
Protein name | Small G protein signaling modulator 1 Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2) |
Synonyms | RUTBC2 KIAA1941 |
Description | FUNCTION: Interacts with numerous Rab family members, functioning as Rab effector for some, and as GTPase activator for others. Promotes GTP hydrolysis by RAB34 and RAB36. Probably functions as a GTPase effector with RAB9A and RAB9B; does not stimulate GTP hydrolysis with RAB9A and RAB9B. . |
Accessions | ENST00000400358.9 [Q2NKQ1-4] ENST00000400359.4 [Q2NKQ1-1] ENST00000610372.4 A0A087X241 Q2NKQ1 |